| Literature DB >> 21310791 |
Preetha Rajaraman1, Jill Simpson, Gila Neta, Amy Berrington de Gonzalez, Pat Ansell, Martha S Linet, Elaine Ron, Eve Roman.
Abstract
OBJECTIVE: To examine childhood cancer risks associated with exposure to diagnostic radiation and ultrasound scans in utero and in early infancy (age 0-100 days).Entities:
Mesh:
Year: 2011 PMID: 21310791 PMCID: PMC3037470 DOI: 10.1136/bmj.d472
Source DB: PubMed Journal: BMJ ISSN: 0959-8138

Eligibility, participation, and inclusion in analysis of early life exposure to diagnostic radiation and ultrasound scans in UK Childhood Cancer Study
Demographic characteristics of study participants* with obstetric data, UK Childhood Cancer Study 1976-96. Values are numbers (percentages) unless stated otherwise
| Characteristics | All controls (n=4857) | All cases (n=2690) | Leukaemia (n=1253) | Lymphoma (n=231) | Central nervous system (n=482) |
|---|---|---|---|---|---|
| Age at diagnosis (years): | |||||
| <1 | 471 (9.7) | 250 (9.3) | 74 (5.9) | 0 (0) | 44 (9) |
| 1-4 | 2233 (46.0) | 1195 (44.4) | 665 (53.1) | 48 (21) | 153 (32) |
| 5-9 | 1324 (27.3) | 743 (27.6) | 340 (27.1) | 80 (35) | 182 (38) |
| 10-14 | 829 (17.1) | 502 (18.7) | 174 (13.9) | 103 (45) | 103 (21) |
| Mean (median) age at diagnosis (years) | 5.5 (4.4) | 5.7 (4.6) | 5.3 (4.3) | 9.0 (9.4) | 6.4 (6.1) |
| Male sex | 2688 (55.3) | 1499 (55.7) | 692 (55.2) | 165 (71) | 236 (49) |
| Birth weight (g): | |||||
| <2500 | 289 (6.0) | 137 (5.1) | 62 (4.9) | 13 (6) | 26 (5) |
| 2500-4000 | 4071 (83.8) | 2250 (83.6) | 1046 (83.5) | 196 (85) | 406 (84) |
| ≥4000 | 497 (10.2) | 303 (11.3) | 145 (11.6) | 22 (10) | 50 (10) |
| Multiple birth | 108 (2.2) | 62 (2.3) | 25 (2.0) | 6 (3) | 13 (3) |
| Trisomy 21 | 3 (0.1) | 34 (1.3) | 34 (2.7) | 0 (0) | 0 (0) |
| Mean (median) maternal age at birth (years) | 28.0 (27.8) | 27.5 (27.3) | 27.7 (27.6) | 27.0 (26.6) | 27.2 (26.9) |
| Maternal smoking | 1314 (27.1) | 696 (25.9) | 323 (25.8) | 57 (25) | 128 (27) |
| Maternal pre-eclampsia | 481 (9.9) | 278 (10.3) | 127 (10.1) | 31 (13) | 54 (11) |
| Deprivation at birth: | (n=4834) | (n=2677) | (n=1251) | (n=230) | (n=476) |
| 1 (least) | 906 (18.7) | 469 (17.5) | 238 (19.0) | 27 (12) | 78 (16) |
| 2 | 1006 (20.8) | 564 (21.1) | 254 (20.3) | 48 (21) | 114 (24) |
| 3 | 1076 (22.3) | 560 (20.9) | 241 (19.3) | 56 (24) | 102 (21) |
| 4 | 994 (20.6) | 562 (20.9) | 264 (21.1) | 41 (18) | 104 (22) |
| 5 (most) | 852 (17.6) | 522 (19.5) | 254 (20.3) | 58 (25) | 78 (16) |
*One patient with radiotherapy excluded.
Types of diagnostic examinations in utero and in early infancy, UK Childhood Cancer Study, 1976-96*
| No (%) of procedures; No of participants | |
|---|---|
| Radiation (319 procedures; 305 participants): | |
| Pelvimetry | 204 (64); 196 |
| Chest radiography | 41 (13); 36 |
| Abdominal radiography | 36 (11); 29 |
| Other radiography | 19 (6); 16 |
| Radiography for broken bone | 6 (2); 5 |
| Skull radiography | 2 (1); 1 |
| Computed tomography | 1 (<1); 1 |
| Uncertain | 2 (1); 2 |
| Barium enema† | 2 (1); 2 |
| Salpingogram† | 2 (1); 2 |
| Intravenous pyelogram† | 2 (1); 2 |
| Barium meal† | 1 (<1); 1 |
| Venograph† | 1 (<1); 1 |
| More than one site | 11 participants |
| Ultrasound scans (13 723 procedures; 6516 participants): | |
| Confirmation of pregnancy/routine | 8683 (63.3); 3785 |
| Intrauterine growth restriction scan to check fetal growth | 1434 (10.4); 46 |
| Anomaly scans (routine in some hospitals) | 1010 (7.4); 244 |
| Placental location | 606 (4.4); 27 |
| Other | 1990 (14.5); 124 |
| More than one reason | 2290 participants |
| Radiation (247 procedures; 170 participants): | |
| Chest radiography | 177 (72); 116 |
| Skull radiography | 5 (2); 4 |
| Radiography to look for broken bones | 5 (2); 1 |
| Other | 55 (22); 29 |
| Barium meal† | 2 (1); 1 |
| Barium enema† | 2 (1); 1 |
| Intravenous pyelogram† | 1 (<1); 1 |
| More than one site | 17 participants |
| Ultrasound scans (138 procedures; 107 participants): | |
| Brain | 42 (30); 27 |
| Hips/pelvis | 33 (24); 28 |
| Kidney | 26 (19); 19 |
| Abdominal | 12 (9); 9 |
| Echocardiogram | 7 (5); 5 |
| Chest | 2 (1); 1 |
| Neck | 1 (1); 1 |
| Other | 15 (11); 9 |
| More than one site | 8 participants |
*Excluding participants with trisomy 21 and one participant with radiotherapy. For participant level breakdowns, several children had examinations to more than one site or for more than one reason.
†Radionuclide examinations.
Odds ratios (95% confidence intervals) for childhood cancer associated with any in utero exposure to radiation and ultrasound scans, UK Childhood Cancer Study, 1976-96*
| Cancer | Radiation exposure | Ultrasound exposure | |||||
|---|---|---|---|---|---|---|---|
| No of cases exposed | No of controls exposed | Odds ratio† | No of cases exposed | No of controls exposed | Odds ratio† | ||
| All cancers | 120 | 185 | 1.14 (0.90 to 1.45) | 2282 | 4234 | 0.93 (0.79 to 1.09) | |
| Leukaemia: | 48 | 62 | 1.36 (0.91 to 2.02) | 1074 | 2034 | 0.87 (0.68 to 1.11) | |
| Acute lymphoid | 36 | 53 | 1.20 (0.76 to1.88) | 913 | 1726 | 0.83 (0.63 to 1.09) | |
| Acute myeloid | 11 | 8 | 2.44 (0.95 to 6.33) | 144 | 273 | 1.28 (0.64 to 2.56) | |
| Chronic myeloid | 1 | 1 | – | 15 | 33 | 0.47 (0.06 to 3.56) | |
| Lymphoma: | 16 | 30 | 1.06 (0.55 to 2.06) | 182 | 310 | 1.25 (0.80 to 1.95) | |
| Non-Hodgkin’s | 13 | 18 | 1.48 (0.66 to 3.32) | 131 | 224 | 1.30 (0.75 to 2.25) | |
| Hodgkin’s | 3 | 12 | – | 46 | 80 | 1.03 (0.46 to 2.34) | |
| Brain/central nervous system | 25 | 41 | 1.06 (0.64 to 1.77) | 408 | 731 | 1.08 (0.77 to 1.52) | |
| Sarcoma | 10 | 15 | 1.13 (0.49 to 2.61) | 142 | 271 | 0.69 (0.39 to 1.22) | |
| Peripheral neural tumours | 7 | 13 | 1.00 (0.37 to 2.67) | 155 | 288 | 0.88 (0.46 to 1.69) | |
| Renal | 5 | 6 | 1.64 (0.48 to 5.59) | 130 | 252 | 0.56 (0.28 to 1.13) | |
| Retinoblastoma | 2 | 5 | – | 64 | 118 | 0.84 (0.19 to 3.71) | |
| Gonadal | 1 | 6 | – | 51 | 92 | 1.04 (0.34 to 3.18) | |
| Hepatic | 0 | 3 | – | 22 | 41 | 0.88 (0.11 to 6.80) | |
*Participants with trisomy 21 and one participant with radiotherapy excluded from analysis. Results not shown for categories with fewer than five exposed cases.
†Adjusted for sex of child, age at diagnosis, UKCCS study region, birth weight, maternal age, early infancy radiation (1 year lag), and early infancy ultrasound scans (1 year lag); radiation and ultrasound exposure each adjusted for other.
Odds ratios (95% confidence intervals) for childhood cancer associated with in utero exposure to diagnostic radiation, by decade of birth, by trimester of exposure, and restricted to abdominal exposure, UK Childhood Cancer Study, 1976-96*
| Exposure | All cancers | Leukaemia | |||||
|---|---|---|---|---|---|---|---|
| No of cases exposed | No of controls exposed | Odds ratio† | No of cases exposed | No of controls exposed | Odds ratio† | ||
| Exposure to x ray: | |||||||
| Born in 1970s | 12 | 14 | 1.37 (0.60 to 3.13) | 5 | 3 | 3.58 (0.54 to 23.68) | |
| Born in 1980s | 70 | 116 | 1.06 (0.78 to 1.45) | 26 | 36 | 1.24 (0.73 to 2.11) | |
| Born in 1990s | 38 | 55 | 1.23 (0.80 to 1.90) | 17 | 23 | 1.31 (0.68 to 2.53) | |
| Exposure to x ray: | |||||||
| Trimester 1 | 7 | 9 | 1.27 (0.47 to 3.48) | 2 | 2 | – | |
| Trimester 2 | 12 | 17 | 1.08 (0.51 to 2.28) | 4 | 5 | – | |
| Trimester 3 | 93 | 152 | 1.09 (0.83 to 1.43) | 37 | 52 | 1.27 (0.81 to 1.98) | |
| Restricted to abdominal radiography | 90 | 143 | 1.12 (0.85 to 1.48) | 37 | 54 | 1.21 (0.78 to 1.88) | |
*Participants with trisomy 21 and one participant with radiotherapy excluded from analysis. Results not shown for categories with fewer than five exposed cases.
†Adjusted for sex of child, age at diagnosis, UKCCS study region, maternal age, birth weight, and in utero exposure to ultrasound scans, early infancy radiation, and early infancy ultrasound scans.
Odds ratios (95% confidence intervals) for childhood cancer associated with any exposure to diagnostic radiation or ultrasound scans in early infancy (0-100 days), UK Childhood Cancer Study, 1976-96*
| Cancer | Early infancy radiation exposure | Early infancy ultrasound scan exposure | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 year lag | 2 year lag | 0 year lag | 2 year lag | ||||||||
| No of cases/controls exposed | Odds ratio† | No of cases/controls exposed | Odds ratio† | No of cases/controls exposed | Odds ratio† | No of cases/controls exposed | Odds ratio† | ||||
| All cancers | 68/102 | 1.16 (0.83 to 1.62) | 50/75 | 1.19 (0.82 to 1.74) | 49/58 | 1.92 (1.25 to 2.95) | 25/33 | 1.55 (0.89 to 2.70) | |||
| Leukaemia: | 34/49 | 1.39 (0.87 to 2.23) | 27/40 | 1.35 (0.81 to 2.27) | 16/35 | 0.95 (0.49 to 1.86) | 9/25 | 0.68 (0.30 to 1.53) | |||
| Acute lymphoid | 29/43 | 1.41 (0.85 to 2.35) | 26/34 | 1.55 (0.90 to 2.67) | 13/33 | 0.74 (0.36 to 1.52) | 9/25 | 0.65 (0.29 to 1.45) | |||
| Acute myeloid | 5/5 | 1.63 (0.42 to 6.35) | 1/5 | – | 3/2 | – | 0/0 | – | |||
| Chronic myeloid | 0/0 | – | 0/0 | – | 0/0 | – | 0/0 | – | |||
| Lymphoma | 7/3 | 5.14 (1.27 to 20.78) | 7/3 | 5.14 (1.27 to 20.8) | 1/0 | – | 1/0 | – | |||
| Non-Hodgkin’s | 6/2 | 6.85 (1.31 to 35.69) | 6/2 | 6.85 (1.31 to 35.7) | 1/0 | – | 1/0 | – | |||
| Hodgkin’s | 1/0 | – | 1/0 | – | 0/0 | – | 0/0 | – | |||
| Brain/central nervous system | 9/16 | 0.90 (0.36 to 2.31) | 6/10 | 0.94 (0.31 to 2.92) | 6/7 | 1.90 (0.59 to 6.17) | 4/2 | – | |||
| Peripheral neural tumours | 5/12 | 0.26 (0.05 to 1.33) | 2/8 | – | 8/5 | 8.79 (1.64 to 47.15) | 1/2 | – | |||
| Sarcoma | 4/8 | – | 3/5 | – | 4/3 | – | 3/3 | – | |||
| Renal | 4/6 | – | 3/5 | – | 6/4 | 3.77 (0.87 to 16.36) | 5/0 | – | |||
| Hepatic | 2/1 | – | 1/0 | – | 4/0 | – | 2/0 | – | |||
| Gonadal | 1/2 | – | 0/1 | – | 2/2 | – | 0/1 | – | |||
| Retinoblastoma | 1/2 | – | 0/0 | – | 2/2 | – | 0/0 | – | |||
*Participants with trisomy 21 and one participant with radiotherapy excluded from analysis. Results not shown for categories with fewer than five exposed cases.
†Adjusted for sex of child, age at diagnosis, UKCCS study region, maternal age, birth weight, and in utero exposure to radiation and ultrasound scans; early infancy diagnostic radiation and ultrasound scans each adjusted for other.